Production (Stage)
BiomX Inc.
PHGE
$0.50
-$0.017-3.29%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -58.45% | 85.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.90% | -19.12% | |||
| Operating Income | 8.90% | 19.12% | |||
| Income Before Tax | 47.22% | -250.49% | |||
| Income Tax Expenses | -66.67% | -- | |||
| Earnings from Continuing Operations | 47.23% | -250.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 47.23% | -250.52% | |||
| EBIT | 8.90% | 19.12% | |||
| EBITDA | 0.96% | 25.60% | |||
| EPS Basic | 58.33% | -356.94% | |||
| Normalized Basic EPS | 4.60% | -154.46% | |||
| EPS Diluted | 62.62% | -386.43% | |||
| Normalized Diluted EPS | 4.60% | -154.46% | |||
| Average Basic Shares Outstanding | 26.63% | 11.48% | |||
| Average Diluted Shares Outstanding | 26.63% | 11.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||